Product NDC: | 51224-301 |
Proprietary Name: | Alendronate Sodium |
Non Proprietary Name: | Alendronate Sodium |
Active Ingredient(s): | 70 mg/75mL & nbsp; Alendronate Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51224-301 |
Labeler Name: | TAGI Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090520 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130506 |
Package NDC: | 51224-301-10 |
Package Description: | 4 BOTTLE, UNIT-DOSE in 1 CARTON (51224-301-10) > 75 mL in 1 BOTTLE, UNIT-DOSE |
NDC Code | 51224-301-10 |
Proprietary Name | Alendronate Sodium |
Package Description | 4 BOTTLE, UNIT-DOSE in 1 CARTON (51224-301-10) > 75 mL in 1 BOTTLE, UNIT-DOSE |
Product NDC | 51224-301 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Alendronate Sodium |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20130506 |
Marketing Category Name | ANDA |
Labeler Name | TAGI Pharma, Inc. |
Substance Name | ALENDRONATE SODIUM |
Strength Number | 70 |
Strength Unit | mg/75mL |
Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |